Results 91 to 100 of about 38,224 (238)

Assessment of dose increase after administration of radiopharmaceuticals prepared with cyclotron-produced 99mTc

, 2019
Technetium-99m (99mTc) is currently available from 99Mo/99mTc generators as the β-decay product of 99Mo (T1⁄2=66 h). Nowadays, 99Mo is mostly obtained as a fission product in nuclear reactors by neutron-induced reactions on highly enriched uranium ...
Bello, Michele, Guillermina Ferro-Flores, Michele Bello, Juan Esposito, Esposito, Juan, Alessandra, Zorz, Uzunov, Nikolay Mihaylov, Marta Paiusco, Rosato, Antonio, Laura Melendez-Alafort, Paiusco, Marta, Nikolay Uzunov, Antonio Rosato, Guillermina, Ferro-Flores, Laura De Nardo, Alessandra Zorz, De Nardo, Laura, Melendez Alafort, Laura   +17 more
core  

GMP‐compliant production, validation and dosimetry of clinical grade [18F]3‐(3‐fluoropropyl)‐2‐phenyl‐2,3‐dihydrobenzo[d]thiazole ([18F]FPBT) for oxidative stress PET imaging

British Journal of Pharmacology, Volume 183, Issue 20, Page 6028-6045, October 2026.
Background and Purpose Oxidative stress plays a critical role in the pathophysiology of various diseases, yet current methods for its non‐invasive detection remain limited. This study aimed to systematically validate a superoxide‐selective PET tracer, [18F]FPBT, for the early diagnosis and therapeutic monitoring of oxidative stress‐related conditions ...
Hua Zhang, Fangfang Sun, Chun Li, Xin Wang, Yuexuan Song, Lu Jiang, Paul Gape, Samantha Y. A. Terry, Shujun He, Ran Yan, Zhi Lu   +10 more
wiley   +1 more source

Adverse reactions to therapeutic radiopharmaceuticals

Radiopharmaceuticals are drugs used in treatment or diagnosis that contain a radioactive part, usually a pharmaceutical part in their structure. Adverse drug reactions are harmful and unexpected responses that occur when administered at normal doses ...
Silindir-Gunay, Mine, Ozolmez, NUR
core   +1 more source

Diagnosis and surgical treatment of four radiographically incomplete, articular, proximal third metatarsal bone fractures

Equine Veterinary Education, Volume 38, Issue 10, Page e721-e728, October 2026.
Summary The objective was to describe the diagnosis, surgical repair and outcome of four radiographically incomplete, articular, proximal third metatarsal bone fractures with an uncommon, dorsomedial–plantarolateral oblique configuration and this is a retrospective analysis of four racehorses presenting for surgical treatment of this uncommon fracture ...
M. J. S. Duggan, I. Wright, A. Campos Schweitzer, F. Rossignol, E. Cillán García, W. Schofield   +5 more
wiley   +1 more source

Adverse reactions to positron-emitting radiopharmaceuticals

Radiopharmaceuticals are medicinal products used for the diagnosis or treatment in nuclear medicine, consisting of a radioactive compound and generally a targeting pharmaceutical compound.
Özölmez, NUR, Silindir Günay, Mine
core   +1 more source

Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections

EJNMMI Radiopharmacy and Chemistry
Background The urgent demand for innovative theranostic strategies to combat bacterial resistance to antibiotics is evident, with substantial implications for global health. Rapid diagnosis of life-threatening infections can expedite treatment, improving
Jyotsna Bhatt Mitra, Saurav Chatterjee, Anuj Kumar, Elina Khatoon, Ashok Chandak, Sutapa Rakshit, Anupam Bandyopadhyay, Archana Mukherjee   +7 more
doaj   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1791-1806, September 2026.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Separation of Radiocopper 64/67Cu from the Matrix of Neutron-Irradiated Natural Zinc Applicable for 64Cu Production

Atom Indonesia, 2012
Radioisotope 64Cu is a promising radiometallic-isotope for molecular-targeted-radiopharmaceuticals. Having a half-life of 12.70 hours and emitting β+-radiation (E+ = 0.6531 MeV) as well as β—ray (E = 0.5787 MeV), it is widely used in the form of ...
S. Soenarjo, Sriyono, W.Y. Rahman, E. Sarmini, Hambali , Triyanto   +5 more
doaj  

Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions

Med Research, EarlyView.
Zhiwu Dong, Sixiang Yan, Xiaodong Liu, Peng Gu   +3 more
wiley   +1 more source

Oligonucleotides as Radiopharmaceuticals

, 2006
Oligonucleotide radiopharmaceuticals is a slowly but steadily progressing field. With a panel of labeling and imaging techniques mastered by several groups, imaging of oligonucleotides is now relatively accessible and will be applied to more and more trials of oligonucleotide pharmacology.
openaire   +2 more sources